Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to assess before, as well as 6 and 12 months following a
therapy with benfotiamine the influence of therapy on intraepidermal nerve fiber density
(skin biopsy) and neuropathic symptoms and deficits in people with type 1 or 2 diabetes
mellitus and diabetic sensomotoric neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Diabetes Schwerpunktpraxis
Collaborators:
Woerwag Pharma GmbH & Co. KG Woerwag Pharma GmbH and Co. KG